Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Intraocular delivery of ketorolac will be an effective means to treat inflammation and
macular edema and prevent structural complications and vision loss in patients with uveitis
who are unable to tolerate corticosteroids due to their side effects.